Skip to main content
. 2023 Mar 2;75(3):1480–1489. doi: 10.1007/s12070-023-03516-8

Table 2.

Tumor and treatment details in the two groups of patients

Control (N = 65) Triphala (N = 37) Chi square/unpaired t test
Tumor Size (T) T1 2 (3.08) 1 (2.7)
T2 29 (44.62) 14 (37.84)
T3 19 (29.23) 11 (29.73)
T4 12 (18.46) 9 (24.32)
TX 3 (4.62) 1 (2.7)
Nodes N0 22 (33.85) 13 (35.14)
N1 25 (38.46) 15 (40.54)
N2 15 (23.08) 7 (18.92)
N3 2 (3.08) 1 (2.7)
NX 1 (1.54) 1 (2.7)
Metastasis M0 53 (81.54) 29 (78.38)
MX 12 (18.46) 8 (21.62)
Surgery before radiation Yes 23 (35.38) 16 (43.24)
No 42 (64.62) 21 (56.76)

Radiation type

and dose

Radiation only 28 (43.08) 12 (32.43)
Chemo-radiation 37 (56.92) 25 (67.57)
Radiation fraction 33.43 ± 2.03 33.65 ± 1.75
Radiation dose 66.9 ± 4.05 67.30 ± 3.50
Early incidence of treatment breaks (before week 4) No treatment breaks 59 (90.77) 36 (97.3)
Treatment breaks 6 (9.23) 1 (2.70)
Late incidence of treatment breaks (after week 4) No treatment breaks 52 (80.00) 36 (97.29)
Treatment breaks 13 (20.00) 3 (8.11)
Total incidence of treatment breaks No treatment breaks 46 (70.77) 33 (89.19) Chi square P = 0.032
Treatment breaks 19 (29.23) 4 (10.81)
Treatment days lost 6.78 ± 0.54 5.00 ± 3.43 t test P = 0.02
Feeding tube Yes 18 (27.69) 7 (18.92)
No 47 (72.31) 30 (81.08)
Mucositis Intolerable 54 (83.08) 27 (72.97)
Tolerable 11 (16.92) 10 (27.03)
Opiod use Yes 49 (75.38) 19 (51.35) Chi square P = 0.013
No 16 (24.62) 18 (48.65)
Weight loss Initial weight 53.40 ± 11.11 52.29 ± 14.87
Final weight 49.72 ± 10.80 49.32 ± 14.39
Weight change 3.66 ± 1.70 2.97 ± 1.52 t test P = 0.038
Less than 2 kg 27 (41.54) 21 (56.76)
2.1 to 5 kg 30 (46.15) 14 (37.84)
More than 5 kg 9 (13.85) 2 (5.41)
Treatment response Complete Response 45 (69.23) 28 (75.68)
Partial response 11 (16.92) 4 (10.81)
No response 9 (13.85) 5 (13.51)